TY - JOUR AU - Robert, N J; DiƩras, V; Glaspy, J TI - RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2-negative, Locally Recurrent or Metastatic Breast Cancer JO - J Clin Oncol VL - 29 PY - 2011 DO - 10.1200/JCO.2010.28.0982 L3 - PubMed-ID: 21383283 SP - 1252 EP - 1260 N1 - et al. ER -